In recent years, embolotherapy has become one of the core components of interventional radiology. While its established therapies remain essential for both IR and the medical community at large, embolotherapy is also an incredibly versatile field, constantly pushing the boundaries of innovation and embracing new clinical applications. With the support of an industry continuously pushing for improvements in tools and materials, cutting-edge embolisation treatments can be offered to an ever-growing number of patients. CIRSE strives to support this development through the European Conference on Embolotherapy (ET), providing interventional radiologists with the ideal platform to advance embolotherapy to become even more precise, evidence-based and impactful.
The debut of ET was a brilliant success, bringing together more than 800 medical experts to widen their knowledge, share their experience and explore the latest technology. ET 2019 exceeded expectations across the spectrum, pushing embolotherapy education into high gear and exploring both established and novel therapies with new tools for educational interaction.
While we very much hoped that vaccination campaigns would make it possible for us to meet in person for the 2021 meeting, we must now acknowledge that it will continue to take some time before things can go back to normal and we can travel again. However, if there is one thing the last year has taught us, it’s adaptability. We are therefore excited to invite you to join us online for ET 2021 from June 17-19 for a conference boasting the same high quality educational content, safely accessible for participants all across the world.
This year’s scientific programme features a wide range of topics presented by renowned faculty, exploring both fundamental and controversial topics, investigating the most recent data as well as real cases, offering a wealth of knowledge and experience to a diverse group of participants. Established therapy sessions will cover the latest updates in some of embolotherapy’s most essential topics, such as TACE for primary liver cancer, PAE, UFE and TARE. Special topic sessions will investigate some of the most avant-garde embolotherapy treatments, such as for haemorrhoids, trauma and low-flow AVMs.
Case remedy sessions are another key feature of the programme, engaging in a thorough discussion on some of the most difficult procedures in a variety of areas such as UAE for cases other than fibroids, endoleak, and GI bleeding. Harnessing the ET’s focus on technological innovations, technical focus sessions will investigate both new and established devices and materials, such as microcatheters and microwaves, particles, liquids and much more!
This mixture of advanced educational opportunities and in-depth exploration of new technology is what will push the field of embolotherapy even further, and ET will continue to provide this opportunity to connect with embolisation specialists as one of the most fundamental aspects for future growth.
We look forward to seeing you online!